Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Search results for:
lovastatin
lovastatin
Therapeutic Interchange:
Autosub Lovastatin 20 mg daily to Pravastatin 20 mg daily
Therapeutic Interchange:
Autosub Lovastatin 40 mg daily to Atorvastatin 10 mg daily
Therapeutic Interchange:
Autosub Lovastatin 80 mg daily to Atorvastatin 20 mg daily
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
Mevacor
TABLET, ORAL
10 mg, 20 mg, 40 mg
VIEW MORE
HMG-CoA Reductase Inhibitors
CLASS
240608
Additional Information:
Drug Name
Common Side Effects
Lovastatin
GI: flatulence, abdominal pain, constipation
headache
muscle pain, tenderness or weakness
Last updated:
Sep. 23, 2022
Do Not Crush:
Extended-release Tablet
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Rhazdrugs:
lovastatin
Lovastatin